Warning letter
Integra LifeSciences Corporation: warning letter of Jul 17, 2023
FDA warning letter 660960 · Division of Medical Device and Radiological Health Division I
Key facts
| Reference number | 660960 |
|---|---|
| Company | Integra LifeSciences Corporation |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Jul 17, 2023 |
| Posted date | Aug 15, 2023 |
| Issuing office | Division of Medical Device and Radiological Health Division I |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Boston |
| Inspection ZIP | 02127 |
| Inspection start date | Mar 1, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: